Albendazole
- Generic Name
- Albendazole
- Brand Names
- Albenza
- Drug Type
- Small Molecule
- Chemical Formula
- C12H15N3O2S
- CAS Number
- 54965-21-8
- Unique Ingredient Identifier
- F4216019LN
- Background
A benzimidazole broad-spectrum anthelmintic structurally related to mebendazole that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38)
- Indication
For the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium and for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.
- Associated Conditions
- Hydatid disease of the Liver, Hydatid disease of the Lung, Hydatid disease of the Peritoneum, Neurocysticercosis
- Associated Therapies
- -
The Role of Adjuvant Albendazole After Pulmonary Hydatid Cyst Resection
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 24
- Registration Number
- NCT06483880
- Locations
- 🇪🇬
Ain Shams University Hospitals, Cairo, Al Abbasiya, Egypt
Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis
- Conditions
- Interventions
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- R-Evolution Worldwide S.r.l. Impresa Sociale
- Target Recruit Count
- 300
- Registration Number
- NCT06376396
Specific Versus Empirical Anthelminthic Treatment in Eosinophilia
- Conditions
- Interventions
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Prince of Songkla University
- Target Recruit Count
- 700
- Registration Number
- NCT06265870
- Locations
- 🇹🇭
Prince of Songkla University - Hat Yai Campus: Prince of Songkla University, Hat Yai, Songkhla, Thailand
Improving Cognition and Gestational Duration With Targeted Nutrition
- Conditions
- Interventions
- Dietary Supplement: M-RUSF+ (Maternal Ready-to-Use Supplementary Food + DHA/EPA/choline)Dietary Supplement: M-RUSF (Maternal Ready-to-Use Supplementary Food)Drug: AzithromycinDrug: AlbendazoleDrug: Sulfadoxine pyrimethamineBehavioral: Cognitive behavioral therapyOther: Insecticide-treated mosquito net
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 1600
- Registration Number
- NCT05949190
- Locations
- 🇸🇱
Blama Massaquoi, Blama Massaquoi, Southern, Sierra Leone
🇸🇱Sahn Malen, Sahn, Southern, Sierra Leone
🇸🇱Zimmi, Zimmi, Southern, Sierra Leone
Pharmacokinetics and Excretion of Albendazole and Its Metabolites in Saliva
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- Universidad Nacional de Salta
- Target Recruit Count
- 12
- Registration Number
- NCT05453045
Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 600
- Registration Number
- NCT05354258
- Locations
- 🇸🇳
Saraya Health Centre, Saraya, Kedougou, Senegal
Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal Worms
- Conditions
- Interventions
- First Posted Date
- 2021-11-18
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Barcelona Institute for Global Health
- Target Recruit Count
- 992
- Registration Number
- NCT05124691
- Locations
- 🇪🇹
Bahir Dar University, Colleges of Medicine and Health Sciences (BDU-CMHS), Bahir Dar, Ethiopia
🇰🇪Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
🇲🇿Centro de Investigação em Saúde da Manhiça (CISM), Manhiça, Maputo, Mozambique
Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection
- Conditions
- Interventions
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 153
- Registration Number
- NCT04913610
- Locations
- 🇨🇩
Hôpital Général de Référence de Kimpese, Kimpese, Kongo Central, Congo, The Democratic Republic of the
🇨🇩Hôpital Général de Référence de Masi-Manimba, Masi-Manimba, Kwilu, Congo, The Democratic Republic of the
A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2023-09-18
- Lead Sponsor
- Asociacion Benefica Prisma
- Target Recruit Count
- 249
- Registration Number
- NCT04713787
- Locations
- 🇵🇪
Policlinico Asociacion Benefica PRISMA-Laboratorio Satelite IQTLAB, Iquitos, Maynas, Peru
Moxidectin for LF, Cote d'Ivoire (DOLF)
- Conditions
- Interventions
- First Posted Date
- 2020-06-01
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 164
- Registration Number
- NCT04410406
- Locations
- 🇨🇮
Regional Hospital of Agboville, Southern Cote d'Ivoire, Agboville, Côte D'Ivoire
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.